TOT Biopharm Co. Ltd. has completed the first stage of construction of its $100 million factory complex in eastern China's Suzhou Industrial Park. The 50,000-sq.-m. facility complex specializes in the R&D, production and marketing of anti-cancer drugs globally. The company's core products include liposomal technology-based specialty drugs, biologics and innovative drugs.
The first stage of the new factory complex includes an oral anti-cancer drug plant with separate production facilities for cytotoxics and non-cytotoxics, an injected anti-cancer drug plant, and a GMP pilot plant with 500L cell culture/ purification/filling capacity. The company will begin the second-stage of construction to expand its production scale.
TOT Biopharm Opens Suzhou Production Facility
Published December 3, 2012
blog comments powered by Disqus